跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRISM0CAL B22K0/0 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRISM0CAL B22K0/0
Authorized
STANDARD
PRISM0CAL B22K0/0
Vantive ULC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
edba1c0de070ac2e
Company
Vantive ULC
Type
Standard
Approval Details
Approval Id
edba1c0de070ac2e
Drug Approval Canada Name
PRISM0CAL B22K0/0
Product Name
PRISM0CAL B22K0/0
Status
Marketed
Status Date
2024-04-19
Original Market Date
2016-06-18
Din
02441691
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Haemodialysis , Intravenous
Schedule
Ethical
Ahfs
40:34.00*
Atc Original
B05ZB HEMOFILTRATES
Atc Name
b 05 zb
Aig Number
0321275007
Company Name
Vantive ULC
Company Address
6675 Millcreek Drive, Unit 2, Mississauga, Ontario, Canada, L5N 5M4
Active Ingredients
MAGNESIUM CHLORIDE
3.05 G / L
SODIUM BICARBONATE
2.12 G / L
SODIUM CHLORIDE
7.14 G / L
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
edba1c0de070ac2e
Type
Standard
Back to Health Canada Approvals